Annual Retained Earnings
-$388.43 M
-$55.34 M-16.61%
31 December 2023
Summary:
Verona Pharma annual retained earnings is currently -$388.43 million, with the most recent change of -$55.34 million (-16.61%) on 31 December 2023. During the last 3 years, it has fallen by -$181.38 million (-87.60%). VRNA annual retained earnings is now -869077.63% below its all-time high of $44.70 thousand, reached on 31 December 2005.VRNA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$528.48 M
-$43.17 M-8.89%
30 September 2024
Summary:
Verona Pharma quarterly retained earnings is currently -$528.48 million, with the most recent change of -$43.17 million (-8.89%) on 30 September 2024. Over the past year, it has dropped by -$154.43 million (-41.28%). VRNA quarterly retained earnings is now -1182379.64% below its all-time high of $44.70 thousand, reached on 31 December 2005.VRNA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.6% | -41.3% |
| 3 y3 years | -87.6% | -119.9% |
| 5 y5 years | -346.0% | -359.2% |
VRNA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.6% | at low | -119.9% | at low |
| 5 y | 5 years | -346.0% | at low | -359.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Verona Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$528.48 M(+8.9%) |
| June 2024 | - | -$485.31 M(+17.1%) |
| Mar 2024 | - | -$414.40 M(+6.7%) |
| Dec 2023 | -$388.43 M(+16.6%) | -$388.43 M(+3.8%) |
| Sept 2023 | - | -$374.05 M(+4.2%) |
| June 2023 | - | -$359.14 M(+2.6%) |
| Mar 2023 | - | -$350.11 M(+5.1%) |
| Dec 2022 | -$333.10 M(+26.3%) | -$333.10 M(+3.3%) |
| Sept 2022 | - | -$322.44 M(+5.1%) |
| June 2022 | - | -$306.65 M(+6.2%) |
| Mar 2022 | - | -$288.74 M(+9.5%) |
| Dec 2021 | -$263.72 M(+27.4%) | -$263.72 M(+9.8%) |
| Sept 2021 | - | -$240.29 M(-4.4%) |
| June 2021 | - | -$251.26 M(+10.0%) |
| Mar 2021 | - | -$228.37 M(+10.3%) |
| Dec 2020 | -$207.05 M(+46.0%) | -$207.05 M(+15.0%) |
| Sept 2020 | - | -$180.04 M(+24.4%) |
| June 2020 | - | -$144.71 M(+6.2%) |
| Mar 2020 | - | -$136.27 M(-3.9%) |
| Dec 2019 | -$141.78 M(+62.8%) | -$141.78 M(+23.2%) |
| Sept 2019 | - | -$115.09 M(+8.7%) |
| June 2019 | - | -$105.84 M(+8.8%) |
| Mar 2019 | - | -$97.24 M(+11.7%) |
| Dec 2018 | -$87.09 M(+30.8%) | -$87.09 M(+1.0%) |
| Sept 2018 | - | -$86.23 M(+3.3%) |
| June 2018 | - | -$83.48 M(-7.7%) |
| Mar 2018 | - | -$90.40 M(+35.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | -$66.56 M(+87.8%) | -$66.56 M(+15.6%) |
| Sept 2017 | - | -$57.58 M(+30.7%) |
| June 2017 | - | -$44.05 M(+24.3%) |
| Dec 2016 | -$35.44 M(+0.7%) | -$35.44 M(+7.9%) |
| June 2016 | - | -$32.84 M(-6.7%) |
| Dec 2015 | -$35.19 M(+43.7%) | -$35.19 M(+15.4%) |
| June 2015 | - | -$30.50 M(+24.6%) |
| Dec 2014 | -$24.49 M(+13.1%) | -$24.49 M(-0.7%) |
| June 2014 | - | -$24.65 M(+13.9%) |
| Dec 2013 | -$21.65 M(+26.1%) | -$21.65 M(+22.4%) |
| June 2013 | - | -$17.69 M(+3.1%) |
| Dec 2012 | -$17.16 M(+34.6%) | -$17.16 M(+17.8%) |
| June 2012 | - | -$14.57 M(+14.3%) |
| Dec 2011 | -$12.75 M(+26.7%) | -$12.75 M(+5.9%) |
| June 2011 | - | -$12.04 M(+19.6%) |
| Dec 2010 | -$10.07 M(+33.4%) | -$10.07 M(+22.7%) |
| June 2010 | - | -$8.20 M(+8.6%) |
| Dec 2009 | -$7.55 M(+62.5%) | -$7.55 M(+19.5%) |
| June 2009 | - | -$6.32 M(+36.1%) |
| Dec 2008 | -$4.64 M(+30.2%) | -$4.64 M(-4.3%) |
| June 2008 | - | -$4.85 M(+36.0%) |
| Dec 2007 | -$3.57 M(+212.9%) | -$3.57 M(+70.8%) |
| June 2007 | - | -$2.09 M(+83.2%) |
| Dec 2006 | -$1.14 M(-2651.0%) | -$1.14 M(+2105.6%) |
| June 2006 | - | -$51.70 K(-215.7%) |
| Dec 2005 | $44.70 K | $44.70 K(-231.5%) |
| June 2005 | - | -$34.00 K |
FAQ
- What is Verona Pharma annual retained earnings?
- What is the all time high annual retained earnings for Verona Pharma?
- What is Verona Pharma annual retained earnings year-on-year change?
- What is Verona Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Verona Pharma?
- What is Verona Pharma quarterly retained earnings year-on-year change?
What is Verona Pharma annual retained earnings?
The current annual retained earnings of VRNA is -$388.43 M
What is the all time high annual retained earnings for Verona Pharma?
Verona Pharma all-time high annual retained earnings is $44.70 K
What is Verona Pharma annual retained earnings year-on-year change?
Over the past year, VRNA annual retained earnings has changed by -$55.34 M (-16.61%)
What is Verona Pharma quarterly retained earnings?
The current quarterly retained earnings of VRNA is -$528.48 M
What is the all time high quarterly retained earnings for Verona Pharma?
Verona Pharma all-time high quarterly retained earnings is $44.70 K
What is Verona Pharma quarterly retained earnings year-on-year change?
Over the past year, VRNA quarterly retained earnings has changed by -$154.43 M (-41.28%)